Journal of Lipid and Atherosclerosis

SJR Rank #1,666H-index: 26SJR: 1.844Best quartile: Q1Open Access (Diamond, no APC)Listed in DOAJ

Journal website: aims, scope and author guidelines

Publisher

Korean Society of Lipid and Atherosclerosis

Country

South Korea

Type

journal

SJR by Edition

Subject Categories

Cardiology and Cardiovascular MedicineQ1
Endocrinology, Diabetes and MetabolismQ1
Internal MedicineQ1

Areas: Medicine

Most published research topics

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and LipoproteinsCancer, Lipids, and MetabolismAdipokines, Inflammation, and Metabolic DiseasesAtherosclerosis and Cardiovascular DiseasesLipid metabolism and disordersCardiac Imaging and DiagnosticsDiet and metabolism studiesCoronary Interventions and DiagnosticsLiver Disease Diagnosis and Treatment

Source: OpenAlex

Publication Statistics

Documents per Year

Detailed Information

ISSN

2287-2892, 2288-2561

SJR Best Quartile

Region

Asiatic Region

Citations per Document (2 years)

6.00

References per Document

44.61

Coverage

2019-2026

Scope

The Journal of Lipid and Atherosclerosis (JLA), an international and peer-reviewed journal, is the official journal of the Korean Society of Lipid and Atherosclerosis. Its abbreviated title is ‘J Lipid Atheroscler (JLA)’. The JLA is published 3 times a year (January 25, May 25, and September 25). The JLA aims to advance knowledge of the mechanisms responsible for lipid metabolism and atherosclerosis and enhance insight into prevention, treatment, and ultimate cure for cardiovascular diseases. The JLA covers basic, translational, and clinical research of lipid and atherosclerosis. The JLA also encourages articles on broad aspects of vascular biology, thrombosis, metabolism, nutrition, or cardiovascular health. Manuscripts may be submitted as original articles or reviews. The JLA is published online only, and includes key words indexing with Medical Subject Heading (MeSH) terms.

Metrics from SCImago Journal Rank 2025. View on SCImago